Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

High neutrophil‐to‐lymphocyte ratio (NLR) is associated with treatment failure and death in patients who have melanoma treated with PD‐1 inhibitor monotherapy
Edmund K. Bartlett, Jessica Flynn, Katherine S. Panageas, et al.
Cancer (2019) Vol. 126, Iss. 1, pp. 76-85
Open Access | Times Cited: 124

Showing 1-25 of 124 citing articles:

Pretreatment neutrophil-to-lymphocyte ratio and mutational burden as biomarkers of tumor response to immune checkpoint inhibitors
Cristina Valero, Mark Lee, Douglas R. Hoen, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 325
ImmuneLENS characterizes systemic immune dysregulation in aging and cancer
Robert Bentham, Thomas P. Jones, James R. Black, et al.
Nature Genetics (2025)
Open Access | Times Cited: 2
Predictive value of neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in advanced hepatocellular carcinoma patients treated with anti–PD‐1 therapy
Sirish Dharmapuri, Umut Özbek, Jung‐Yi Lin, et al.
Cancer Medicine (2020) Vol. 9, Iss. 14, pp. 4962-4970
Open Access | Times Cited: 107
Three-year survival, correlates and salvage therapies in patients receiving first-line pembrolizumab for advanced Merkel cell carcinoma
Paul Nghiem, Shailender Bhatia, Evan J. Lipson, et al.
Journal for ImmunoTherapy of Cancer (2021) Vol. 9, Iss. 4, pp. e002478-e002478
Open Access | Times Cited: 100
Predictive biomarkers for response to immune checkpoint inhibition
Benjamin Shum, James Larkin, Samra Turajlic
Seminars in Cancer Biology (2021) Vol. 79, pp. 4-17
Closed Access | Times Cited: 96
Association of systemic inflammation with survival in patients with cancer cachexia: results from a multicentre cohort study
Qi Zhang, Mengmeng Song, Xi Zhang, et al.
Journal of Cachexia Sarcopenia and Muscle (2021) Vol. 12, Iss. 6, pp. 1466-1476
Open Access | Times Cited: 88
Systemic inflammation and pro-inflammatory cytokine profile predict response to checkpoint inhibitor treatment in NSCLC: a prospective study
Diego Kauffmann‐Guerrero, Kathrin Kahnert, Rosemarie Kiefl, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 58
Baseline and early changes in the neutrophil–lymphocyte ratio (NLR) predict survival outcomes in advanced colorectal cancer patients treated with immunotherapy
Hui Ouyang, Bijing Xiao, Yan Huang, et al.
International Immunopharmacology (2023) Vol. 123, pp. 110703-110703
Open Access | Times Cited: 34
Peripheral blood inflammatory biomarkers dynamics reflect treatment response and predict prognosis in non‐small cell lung cancer patients with neoadjuvant immunotherapy
Qilin Huai, Chenyu Luo, Peng Song, et al.
Cancer Science (2023) Vol. 114, Iss. 12, pp. 4484-4498
Open Access | Times Cited: 30
Pretreatment neutrophil-to-lymphocyte ratio is associated with immunotherapy efficacy in patients with advanced cancer: a systematic review and meta-analysis
Jialin Su, Li Yu-ning, Shuhua Tan, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Prognostic value of combined NP and LHb index with absolute monocyte count in colorectal cancer patients
Kuan Wang, Kejin Li, Ziyi Zhang, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access | Times Cited: 1
High neutrophil-to-lymphocyte ratio associated with progression to critical illness in older patients with COVID-19: a multicenter retrospective study
Jiangshan Lian, Ciliang Jin, Shaorui Hao, et al.
Aging (2020) Vol. 12, Iss. 14, pp. 13849-13859
Open Access | Times Cited: 52
Inflammatory Markers Predict Survival in Patients With Advanced Gastric and Colorectal Cancers Receiving Anti–PD-1 Therapy
Xiaona Fan, Dan Wang, Wenjing Zhang, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 49
Post treatment NLR is a predictor of response to immune checkpoint inhibitor therapy in patients with esophageal squamous cell carcinoma
Xianbin Wu, Runkun Han, Yanping Zhong, et al.
Cancer Cell International (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 39
Peripheral Blood Markers Associated with Immune-Related Adverse Effects in Patients Who Had Advanced Non-Small Cell Lung Cancer Treated with PD-1 Inhibitors
Wenhui Liu, Yiping Liu, Fang Ma, et al.
Cancer Management and Research (2021) Vol. Volume 13, pp. 765-771
Open Access | Times Cited: 35
Prognostic significance of cachexia in advanced non-small cell lung cancer patients treated with pembrolizumab
Hitomi Jo, Tatsuya Yoshida, Hidehito Horinouchi, et al.
Cancer Immunology Immunotherapy (2021) Vol. 71, Iss. 2, pp. 387-398
Open Access | Times Cited: 33
PD-1 Inhibitor Combined With Radiotherapy and GM-CSF (PRaG) in Patients With Metastatic Solid Tumors: An Open-Label Phase II Study
Yuehong Kong, Xiangrong Zhao, Meiling Xu, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 27
Basal and one-month differed neutrophil, lymphocyte and platelet values and their ratios strongly predict the efficacy of checkpoint inhibitors immunotherapy in patients with advanced BRAF wild-type melanoma
Michele Guida, Nicola Bartolomeo, Davide Quaresmini, et al.
Journal of Translational Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 26
Diverse Neutrophil Functions in Cancer and Promising Neutrophil-Based Cancer Therapies
Khetam Sounbuli, Н. Л. Миронова, Л. А. Алексеева
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 24, pp. 15827-15827
Open Access | Times Cited: 26
Pretreatment Neutrophil-to-Lymphocyte Ratio as a Prognostic Biomarker in Unresectable or Metastatic Esophageal Cancer Patients With Anti-PD-1 Therapy
Yiming Gao, Zhibo Zhang, Yao Li, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 22
Baseline Serum neutrophil-to-lymphocyte ratio in acral melanoma compared with nonacral melanoma and its prognostic significance
Myoung Eun Choi, Joon Min Jung, Do Hyung Kim, et al.
Journal of the American Academy of Dermatology (2024) Vol. 90, Iss. 5, pp. 977-985
Closed Access | Times Cited: 5
Translational Frontiers and Clinical Opportunities of Immunologically Fitted Radiotherapy
Daphné Morel, Charlotte Robert, Nikos Paragios, et al.
Clinical Cancer Research (2024) Vol. 30, Iss. 11, pp. 2317-2332
Open Access | Times Cited: 5
Endotoxin-Free Outer Membrane Vesicles for Safe and Modular Anticancer Immunotherapy
Mei-Yi Chen, Ting-Wei Cheng, Yi‐Chung Pan, et al.
ACS Synthetic Biology (2025) Vol. 14, Iss. 1, pp. 148-160
Open Access
Risk factors for mortality in patients with primary biliary cholangitis: a nomogram to predict 5-year survival
Y Liu, Ming Gao, Bin Li, et al.
Frontiers in Gastroenterology (2025) Vol. 4
Open Access
Recent developments on checkpoint inhibitors, CAR T cells, and beyond for T cell-based immunotherapeutic strategies against cancer
Shaukat Ali, Mahnoor Arshad, Muhammad Summer, et al.
Journal of Oncology Pharmacy Practice (2025)
Closed Access
Page 1 - Next Page

Scroll to top